Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    January 2019
  1. SHI Y, Yin J, Hu H, Xue M, et al
    Targeted regulation of sympathetic activity in paraventricular nucleus reduces inducible ventricular arrhythmias in rats after myocardial infarction.
    J Cardiol. 2019;73:81-88.
    PubMed     Text format     Abstract available


  2. ONO T, Ikemura N, Kimura T, Ueda I, et al
    Contemporary trend of reduced-dose non-vitamin K anticoagulants in Japanese patients with atrial fibrillation: A cross-sectional analysis of a multicenter outpatient registry.
    J Cardiol. 2019;73:14-21.
    PubMed     Text format     Abstract available


    December 2018
  3. ISO K, Watanabe I, Okumura Y, Nagashima K, et al
    No association between dormant conduction sites and pulmonary vein reconnection sites in late atrial fibrillation recurrence after catheter ablation.
    J Cardiol. 2018;72:488-493.
    PubMed     Text format     Abstract available


    November 2018
  4. KORETSUNE Y, Yamashita T, Yasaka M, Ono Y, et al
    Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.
    J Cardiol. 2018 Nov 23. pii: S0914-5087(18)30293.
    PubMed     Text format     Abstract available


    October 2018
  5. SAITO Y, Kobayashi Y
    Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    J Cardiol. 2018 Oct 4. pii: S0914-5087(18)30247.
    PubMed     Text format     Abstract available


    August 2018
  6. FUKAMACHI D, Hirayama A, Miyauchi K, Yasuda S, et al
    Corrigendum to "Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology" [J. Cardiol. 72 (2) (2018) 113-1
    J Cardiol. 2018 Aug 7. pii: S0914-5087(18)30208.
    PubMed     Text format    


    July 2018
  7. HAMADA R, Muto S
    Simple risk model and score for predicting of incident atrial fibrillation in Japanese.
    J Cardiol. 2018 Jul 28. pii: S0914-5087(18)30198.
    PubMed     Text format     Abstract available


    June 2018
  8. ITO M, Yamabe H, Koyama J, Kanazawa H, et al
    Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.
    J Cardiol. 2018 Jun 20. pii: S0914-5087(18)30144.
    PubMed     Text format     Abstract available


  9. SHINOHARA M, Fujino T, Yao S, Yano K, et al
    Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation.
    J Cardiol. 2018 Jun 10. pii: S0914-5087(18)30147.
    PubMed     Text format     Abstract available


    May 2018
  10. SANNA GD, Gabrielli E, De Vito E, Nusdeo G, et al
    Atrial fibrillation in athletes: From epidemiology to treatment in the novel oral anticoagulants era.
    J Cardiol. 2018 May 28. pii: S0914-5087(18)30123.
    PubMed     Text format     Abstract available


  11. YAMAGUCHI T, Tsuchiya T, Fukui A, Kawano Y, et al
    Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation.
    J Cardiol. 2018 May 25. pii: S0914-5087(18)30122.
    PubMed     Text format     Abstract available


  12. LEE SH, Jeong MH, Kim JH, Kim MC, et al
    A new risk score for ventricular tachyarrhythmia in acute myocardial infarction with preserved left ventricular ejection fraction.
    J Cardiol. 2018 May 17. pii: S0914-5087(18)30119.
    PubMed     Text format     Abstract available


  13. BOUREZG A, Bochaton T, Mewton N, Morel O, et al
    Atrial fibrillation, intra-ventricular thrombus, and other anticoagulant indications relationship with adverse outcomes in acute anterior myocardial infarction patients.
    J Cardiol. 2018 May 9. pii: S0914-5087(18)30092.
    PubMed     Text format     Abstract available


  14. SAITO C, Minami Y, Arai K, Haruki S, et al
    Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation.
    J Cardiol. 2018 May 8. pii: S0914-5087(18)30108.
    PubMed     Text format     Abstract available


    April 2018
  15. KIM IS, Kim HJ, Kim TH, Uhm JS, et al
    Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
    J Cardiol. 2018 Apr 26. pii: S0914-5087(18)30093.
    PubMed     Text format     Abstract available


  16. GOYA M, Nagashima M, Hiroshima KI, Hayashi K, et al
    Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    J Cardiol. 2018 Apr 25. pii: S0914-5087(18)30091.
    PubMed     Text format     Abstract available


  17. ANDO SI
    Influence of hypoxia induced by sleep disordered breathing in case of hypertension and atrial fibrillation.
    J Cardiol. 2018 Apr 4. pii: S0914-5087(18)30076.
    PubMed     Text format     Abstract available


  18. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry.
    J Cardiol. 2018 Apr 3. pii: S0914-5087(18)30078.
    PubMed     Text format     Abstract available


    March 2018
  19. ICHIJO S, Miyazaki S, Kusa S, Nakamura H, et al
    Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    J Cardiol. 2018 Mar 30. pii: S0914-5087(18)30063.
    PubMed     Text format     Abstract available


  20. TOMITA H, Sasaki S, Hagii J, Metoki N, et al
    Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    J Cardiol. 2018 Mar 30. pii: S0914-5087(18)30075.
    PubMed     Text format     Abstract available


  21. FUKAMACHI D, Hirayama A, Miyauchi K, Yasuda S, et al
    Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology.
    J Cardiol. 2018 Mar 26. pii: S0914-5087(18)30054.
    PubMed     Text format     Abstract available


  22. STIEGER P, Rana OR, Saygili E, Zazai H, et al
    Impact of internal and external electrical cardioversion on cardiac specific enzymes and inflammation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2018 Mar 12. pii: S0914-5087(18)30048.
    PubMed     Text format     Abstract available


  23. KIM IS, Kim HJ, Kim TH, Uhm JS, et al
    Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2018 Mar 5. pii: S0914-5087(18)30047.
    PubMed     Text format     Abstract available


  24. MIYAZAKI S, Miyauchi K, Hayashi H, Tanaka R, et al
    Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics.
    J Cardiol. 2018 Mar 1. pii: S0914-5087(17)30316.
    PubMed     Text format     Abstract available


    February 2018
  25. OKISHIGE K, Aoyagi H, Nishimura T, Shigeta T, et al
    Characteristics of dormant pulmonary vein conduction induced by adenosine triphosphate in patients with atrial fibrillation undergoing cryoballoon ablation.
    J Cardiol. 2018 Feb 26. pii: S0914-5087(17)30329.
    PubMed     Text format     Abstract available


  26. YOSHIGA Y, Shimizu A, Ueyama T, Ono M, et al
    Strict sequential catheter ablation strategy targeting the pulmonary veins and superior vena cava for persistent atrial fibrillation.
    J Cardiol. 2018 Feb 13. pii: S0914-5087(18)30016.
    PubMed     Text format     Abstract available


  27. SPARTALIS M, Voudris V, Iliopoulos DC, Spartalis E, et al
    The paradox of increased risk of atrial fibrillation following bariatric surgery.
    J Cardiol. 2018 Feb 13. pii: S0914-5087(18)30015.
    PubMed     Text format    


  28. ARAI R, Suzuki S, Semba H, Arita T, et al
    The predictive role of E/e' on ischemic stroke and atrial fibrillation in Japanese patients without atrial fibrillation.
    J Cardiol. 2018 Feb 13. pii: S0914-5087(18)30013.
    PubMed     Text format     Abstract available


  29. YAGI N, Itoh H, Hisamatsu T, Tomita Y, et al
    A challenge for mutation specific risk stratification in long QT syndrome type 1.
    J Cardiol. 2018 Feb 10. pii: S0914-5087(18)30012.
    PubMed     Text format     Abstract available


    January 2018
  30. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
    J Cardiol. 2018 Jan 18. pii: S0914-5087(18)30003.
    PubMed     Text format     Abstract available


  31. YAMAGUCHI T, Shimakawa Y, Mitsumizo S, Fukui A, et al
    Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation.
    J Cardiol. 2018 Jan 12. pii: S0914-5087(18)30001.
    PubMed     Text format     Abstract available


  32. KUMOR M, Lipczynska M, Biernacka EK, Klisiewicz A, et al
    Cardiac arrest and ventricular arrhythmia in adults with Ebstein anomaly and left ventricular non-compaction.
    J Cardiol. 2018 Jan 2. pii: S0914-5087(17)30342.
    PubMed     Text format     Abstract available


  33. MARZAHN C, Koban C, Seifert M, Isotani A, et al
    Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation.
    J Cardiol. 2018;71:101-108.
    PubMed     Text format     Abstract available


    December 2017
  34. KAWAMOTO N, Fujita T, Fukushima S, Shimahara Y, et al
    Late onset of atrial fibrillation in patients undergoing mitral valve repair for type II dysfunction.
    J Cardiol. 2017 Dec 21. pii: S0914-5087(17)30340.
    PubMed     Text format     Abstract available


    November 2017
  35. KONDO Y, Senoo K, Kobayashi Y
    Direct oral anticoagulants for Japanese atrial fibrillation in the elderly.
    J Cardiol. 2017 Nov 16. pii: S0914-5087(17)30279.
    PubMed     Text format    


  36. FUKUMOTO D, Ding WG, Wada Y, Fujii Y, et al
    Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    J Cardiol. 2017 Nov 13. pii: S0914-5087(17)30273.
    PubMed     Text format     Abstract available


  37. HAMADA R, Lee JS, Mori K, Watanabe E, et al
    Influence of abdominal obesity and habitual behaviors on incident atrial fibrillation in Japanese.
    J Cardiol. 2017 Nov 7. pii: S0914-5087(17)30201.
    PubMed     Text format     Abstract available


    October 2017
  38. SWISSA M, Birk E, Dagan T, Abby Naimer S, et al
    Limited fluoroscopy catheter ablation of accessory pathways in children.
    J Cardiol. 2017;70:382-386.
    PubMed     Text format     Abstract available


  39. HARTL S, Dorwarth U, Bunz B, Wankerl M, et al
    Lessons from individualized cryoballoon sizing. Is there a role for the small balloon?
    J Cardiol. 2017;70:374-381.
    PubMed     Text format     Abstract available


    September 2017
  40. BANDO S, Nishikado A, Hiura N, Ikeda S, et al
    Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT).
    J Cardiol. 2017 Sep 29. pii: S0914-5087(17)30237.
    PubMed     Text format     Abstract available


  41. RHYOU HI, Park TH, Cho YR, Park K, et al
    Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI.
    J Cardiol. 2017 Sep 29. pii: S0914-5087(17)30236.
    PubMed     Text format     Abstract available


  42. WATANABE I
    Smoking and risk of atrial fibrillation.
    J Cardiol. 2017 Sep 13. pii: S0914-5087(17)30217.
    PubMed     Text format     Abstract available


  43. IMTIAZ AHMAD M, Mosley CD, O'Neal WT, Judd SE, et al
    Smoking and risk of atrial fibrillation in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    J Cardiol. 2017 Sep 5. pii: S0914-5087(17)30214.
    PubMed     Text format     Abstract available


  44. YAMABE H, Kaikita K, Matsumura T, Iwasa A, et al
    Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    J Cardiol. 2017 Sep 5. pii: S0914-5087(17)30210.
    PubMed     Text format     Abstract available


  45. SHINOHARA M, Fujino T, Koike H, Kitahara K, et al
    Assessment of a novel transdermal selective beta1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    J Cardiol. 2017;70:212-219.
    PubMed     Text format     Abstract available


    August 2017
  46. SHINGU Y, Yokota T, Takada S, Niwano H, et al
    Decreased gene expression of fatty acid binding protein 3 in the atrium of patients with new onset of atrial fibrillation in cardiac perioperative phase.
    J Cardiol. 2017 Aug 11. pii: S0914-5087(17)30193.
    PubMed     Text format     Abstract available


    July 2017
  47. KANDA T, Masuda M, Fujita M, Iida O, et al
    Comparison of the origin and coupling interval between ectopy with and without atrial fibrillation initiation.
    J Cardiol. 2017 Jul 13. pii: S0914-5087(17)30162.
    PubMed     Text format     Abstract available


    June 2017
  48. SAWAMURA A, Okumura T, Hiraiwa H, Aoki S, et al
    Cholesterol metabolism as a prognostic marker in patients with mildly symptomatic nonischemic dilated cardiomyopathy.
    J Cardiol. 2017;69:888-894.
    PubMed     Text format     Abstract available


    May 2017
  49. ITO K, Abe Y, Takahashi Y, Shimada Y, et al
    Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: A study using three-dimensional transesophageal echocardiography.
    J Cardiol. 2017 May 17. pii: S0914-5087(17)30101.
    PubMed     Text format     Abstract available


  50. DEL CAMPO A, Roldan J, Verdejo HE, Zalaquett R, et al
    Increased C-reactive protein plasma levels are not involved in the onset of post-operative atrial fibrillation.
    J Cardiol. 2017 May 12. pii: S0914-5087(17)30099.
    PubMed     Text format     Abstract available


    March 2017
  51. ALONSO A, Lutsey PL, Chen LY, MacLehose RF, et al
    Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.
    J Cardiol. 2017 Mar 17. pii: S0914-5087(17)30029.
    PubMed     Text format    


  52. WANG CH, Cheng ML, Liu MH, Kuo LT, et al
    Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    J Cardiol. 2017 Mar 16. pii: S0914-5087(16)30244.
    PubMed     Text format     Abstract available


    February 2017
  53. WEGNER FK, Silvano M, Bogeholz N, Leitz PR, et al
    Slow pathway modification in patients presenting with only two consecutive AV nodal echo beats.
    J Cardiol. 2017;69:471-475.
    PubMed     Text format     Abstract available


  54. SUGANO A, Seo Y, Yamamoto M, Harimura Y, et al
    Optimal cut-off value of reverse remodeling to predict long-term outcome after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    J Cardiol. 2017;69:456-461.
    PubMed     Text format     Abstract available


    January 2017
  55. POTT A, Messemer M, Petscher K, Iturbe-Orbe M, et al
    Clinical outcome of 2nd generation cryoballoon pulmonary vein isolation in patients over 75 years of age.
    J Cardiol. 2017;69:24-29.
    PubMed     Text format     Abstract available


  56. SASAKI S, Shoji Y, Ishida Y, Kinjo T, et al
    Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    J Cardiol. 2017;69:359-363.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: